Pfizer Announces New Chief Business Innovation Officer

Pfizer Announces New Chief Business Innovation Officer

NEW YORK–(Business enterprise WIRE)–Pfizer Inc. (NYSE: PFE) these days introduced that Aamir Malik has joined the business as Executive Vice President and Main Organization Innovation Officer. Mr. Malik will be a member of Pfizer’s Govt Management Group reporting to Chairman and Main Executive Officer, Albert Bourla. Mr. Malik joins Pfizer from McKinsey & Enterprise, where by he most not long ago served as the Taking care of Partner dependable for the firm’s U.S. functions. Earlier, he led the firm’s International Prescribed drugs & Health care Items observe.

Mr. Malik succeeds John Young, Executive Vice President and Chief Enterprise Officer, who recently introduced his intent to retire immediately after a 34-12 months profession at Pfizer. Mr. Malik begins his job on August 30, 2021 and will operate with John to make certain a seamless transition.

At Pfizer, Mr. Malik will oversee the company’s approach, company development, portfolio administration, pipeline prioritization, and formation of new small business ventures, as effectively as the advancement of revolutionary entry partnerships with payers and governments around the entire world.

“We are delighted to welcome Aamir Malik to our executive leadership workforce in this important role as we enter the subsequent period of innovation for Pfizer and continue our pursuit of the two chopping-edge science and options to reimagine how we do organization for the reward of people and modern society,” mentioned Albert Bourla, Chairman and Chief Govt Officer, Pfizer. “Aamir brings with him 25 several years of working experience acquiring ground breaking development approaches, guiding mergers and acquisitions, and implementing high-influence applications to improve patients’ life and transform general performance for daily life science firms. He is the great chief to drive these initiatives.”

Mr. Malik attained a Bachelor of Science in finance from Indiana University and at this time serves on the University’s Kelley Faculty of Business enterprise Dean’s Council. He is an lively advocate for bettering the lives of individuals with food stuff allergy symptoms and has lived and worked globally like in the U.S., Europe, Asia, Latin America, and Africa.

Bourla included: “Enable me acquire this possibility to thank John for his incredible career at Pfizer and for his exemplary leadership, dedication, and enthusiasm for encouraging sufferers and advancing our purpose, which has experienced a enormous influence on our business. We wish him all the ideal in his retirement.”

About Pfizer: Breakthroughs That Alter Patients’ Lives

At Pfizer, we apply science and our global methods to bring therapies to persons that extend and substantially boost their life. We attempt to established the common for good quality, security and benefit in the discovery, improvement and manufacture of health and fitness care items, together with impressive medications and vaccines. Every single working day, Pfizer colleagues do the job across made and rising marketplaces to progress wellness, prevention, therapies and cures that obstacle the most feared conditions of our time. Reliable with our obligation as 1 of the world’s leading modern biopharmaceutical organizations, we collaborate with well being treatment suppliers, governments and local communities to support and develop accessibility to reputable, economical overall health care about the planet. For a lot more than 170 many years, we have worked to make a variation for all who count on us. We routinely post details that may be significant to buyers on our web page at In addition, to find out more, please go to us on and observe us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at

Disclosure Recognize: The facts contained in this launch is as of August 26, 2021. The Organization assumes no obligation to update forward-wanting statements contained in this release as a end result of new info or future situations or developments.

This release is made up of forward-hunting details about, amid other items, our innovation and progress approaches that are topic to considerable dangers and uncertainties that could bring about real outcomes to differ materially from these expressed or implied by these kinds of statements. Pitfalls and uncertainties include things like, amongst other points, the uncertainties inherent in investigate and improvement the uncertainties inherent in enterprise and economic setting up, together with, without having limitation, hazards linked to Pfizer’s small business and potential clients, adverse developments in Pfizer’s markets, or adverse developments in the U.S. or world wide funds markets, credit markets, regulatory surroundings or economies frequently the impact of COVID-19 on our small business, operations and economic benefits and aggressive developments.

A even more description of dangers and uncertainties can be identified in Pfizer’s Yearly Report on Form 10-K for the fiscal yr ended December 31, 2020 and in its subsequent stories on Variety 10-Q, which include in the sections thereof captioned “Risk Factors” and “Ahead-On the lookout Information and Things That May possibly Influence Upcoming Results”, as properly as in its subsequent studies on Type 8-K, all of which are filed with the U.S. Securities and Trade Fee and obtainable at and